Skip to main content
Erschienen in: World Journal of Surgery 6/2014

01.06.2014

ALPPS for Patients with Colorectal Liver Metastases: Effective Liver Hypertrophy, but Early Tumor Recurrence

verfasst von: Karl J. Oldhafer, Marcello Donati, Robert M. Jenner, Axel Stang, Gregor A. Stavrou

Erschienen in: World Journal of Surgery | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a promising method to increase resectability rates of liver tumors. Little has been published about oncological results so far. This report describes clinical evidence regarding a possible effect of ALPPS on tumor recurrence.

Methods

Ten ALPPS procedures were performed for otherwise non-resectable colorectal liver metastases. Seven of these ten patients had a follow-up of at least 3 months and were analyzed for tumor recurrence.

Results

Six of these seven patients had tumor recurrence to the liver. Three of seven patients presented with lung metastases, occurring earlier than liver metastases in two of three cases. One patient with a follow-up of 3 months had no visible recurrent disease, but increasing carcinoembryonic antigen levels.

Conclusions

The patient group operable only through ALPPS is at high risk for recurrence and early tumor progression. Still, this new method is the only chance for an oncological treatment strategy including a surgical approach and possibly better outcome.
Literatur
1.
Zurück zum Zitat De Santibanez E, Clavien P-A (2012) Playing play-doh to prevent postoperative liver failure. The “alpps” approach. Ann Surg 255(3):415–417CrossRef De Santibanez E, Clavien P-A (2012) Playing play-doh to prevent postoperative liver failure. The “alpps” approach. Ann Surg 255(3):415–417CrossRef
2.
Zurück zum Zitat Schnitzbauer AA, Lang SA, Goessmann H et al (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255(3):405–414PubMedCrossRef Schnitzbauer AA, Lang SA, Goessmann H et al (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255(3):405–414PubMedCrossRef
3.
Zurück zum Zitat Knoefel WT, Gabor I, Rehders A et al (2013) In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg 100:388–394PubMedCrossRef Knoefel WT, Gabor I, Rehders A et al (2013) In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg 100:388–394PubMedCrossRef
4.
Zurück zum Zitat Oldhafer K-J, Donati M, Maghsoudi T et al (2012) Integration of 3D volumetry, portal transection and in situ split procedure: a new surgical strategy for inoperable liver metastasis. J Gastrointest Surg 16(2):415–416PubMedCrossRef Oldhafer K-J, Donati M, Maghsoudi T et al (2012) Integration of 3D volumetry, portal transection and in situ split procedure: a new surgical strategy for inoperable liver metastasis. J Gastrointest Surg 16(2):415–416PubMedCrossRef
5.
Zurück zum Zitat Nagino M, Kamiya J, Nishio H et al (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer; surgical outcome and long-term follow-up. Ann Surg 243:364–372PubMedCentralPubMedCrossRef Nagino M, Kamiya J, Nishio H et al (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer; surgical outcome and long-term follow-up. Ann Surg 243:364–372PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Abulkhir A, Limongelli P, Healey AJ et al (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247:49–57PubMedCrossRef Abulkhir A, Limongelli P, Healey AJ et al (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247:49–57PubMedCrossRef
7.
Zurück zum Zitat Elias D, De BT, Roche A et al (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than of the liver parenchyma. Br J Surg 86:784–788PubMedCrossRef Elias D, De BT, Roche A et al (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than of the liver parenchyma. Br J Surg 86:784–788PubMedCrossRef
8.
Zurück zum Zitat Kokudo N, Tada K, Seki M et al (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267–272PubMedCrossRef Kokudo N, Tada K, Seki M et al (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267–272PubMedCrossRef
9.
Zurück zum Zitat Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237:686–691PubMedCentralPubMed Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237:686–691PubMedCentralPubMed
10.
Zurück zum Zitat Andriani OC (2012) Long-term results with associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Ann Surg 256(3):e5PubMedCrossRef Andriani OC (2012) Long-term results with associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Ann Surg 256(3):e5PubMedCrossRef
11.
Zurück zum Zitat Aloia TA, Vauthey JN (2012) Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost? Ann Surg 256(3):e9PubMedCrossRef Aloia TA, Vauthey JN (2012) Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost? Ann Surg 256(3):e9PubMedCrossRef
12.
Zurück zum Zitat Shindoh J, Vauthey J-N, Zimmitti G et al (2013) Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg 217(1):126–133PubMedCrossRef Shindoh J, Vauthey J-N, Zimmitti G et al (2013) Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg 217(1):126–133PubMedCrossRef
13.
Zurück zum Zitat Donati M, Stavrou GA, Basile F et al (2012) Combination of in situ split and portal ligation: lights and shadows of a new surgical procedure. Ann Surg 256(3):11–12CrossRef Donati M, Stavrou GA, Basile F et al (2012) Combination of in situ split and portal ligation: lights and shadows of a new surgical procedure. Ann Surg 256(3):11–12CrossRef
14.
Zurück zum Zitat Donati M, Stavrou GA, Oldhafer KJ (2013) Current position of ALPPS in the surgical landscape of CRLM treatment proposals. World J Gastroenterol 19(39):6548–6554PubMedCentralPubMedCrossRef Donati M, Stavrou GA, Oldhafer KJ (2013) Current position of ALPPS in the surgical landscape of CRLM treatment proposals. World J Gastroenterol 19(39):6548–6554PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187–196PubMedCrossRef Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187–196PubMedCrossRef
Metadaten
Titel
ALPPS for Patients with Colorectal Liver Metastases: Effective Liver Hypertrophy, but Early Tumor Recurrence
verfasst von
Karl J. Oldhafer
Marcello Donati
Robert M. Jenner
Axel Stang
Gregor A. Stavrou
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 6/2014
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2401-2

Weitere Artikel der Ausgabe 6/2014

World Journal of Surgery 6/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.